Detalhe da pesquisa
1.
Cytokine-induced killer (CIK) cells, successes and challenges: report on the first international conference dedicated to the clinical translation of this unique adoptive cell immunotherapy.
Cancer Immunol Immunother
; 73(2): 21, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279995
2.
A rescue approach in refractory diffuse large B-cell lymphoma with obinutuzumab-redirected cytokine-induced killer cells: a first-in-human case report.
Haematologica
; 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38721751
3.
Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP.
Mol Cell
; 56(5): 617-29, 2014 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25454946
4.
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks.
Cytotherapy
; 22(9): 511-518, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631696
5.
Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes.
J Immunol
; 188(5): 2075-83, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22287712
6.
How can Cytokine-induced killer cells overcome CAR-T cell limits.
Front Immunol
; 14: 1229540, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37675107
7.
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.
J Immunother Cancer
; 9(7)2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272306
8.
Cell-Based Assays for Modeling Xenogeneic Immune Responses.
Methods Mol Biol
; 2110: 99-113, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002904
9.
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells.
Oncoimmunology
; 9(1): 1777046, 2020 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923140
10.
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome.
Nat Commun
; 11(1): 3945, 2020 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32770028
11.
Midgut carcinoid patients display increased numbers of regulatory T cells in peripheral blood with infiltration into tumor tissue.
Acta Oncol
; 48(3): 391-400, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18855160
12.
Immunotherapeutic Strategies for Gastric Carcinoma: A Review of Preclinical and Clinical Recent Development.
Biomed Res Int
; 2017: 5791262, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28781967
13.
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.
Cytokine Growth Factor Rev
; 36: 99-105, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629761
14.
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1.
Oncoimmunology
; 6(8): e1313371, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28919988
15.
Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide.
Adv Healthc Mater
; 6(23)2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945012
16.
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.
Oncoimmunology
; 6(4): e1304338, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28507812
17.
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies.
Oncoimmunology
; 5(8): e1199311, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27622068
18.
The mitochondrial calcium uniporter regulates breast cancer progression via HIF-1α.
EMBO Mol Med
; 8(5): 569-85, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27138568
19.
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer.
Nat Cell Biol
; 18(8): 897-909, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27347849
20.
Metabolic control of YAP and TAZ by the mevalonate pathway.
Nat Cell Biol
; 16(4): 357-66, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24658687